Recent Finacing
Recent Raise
Gemmus Pharma is a San Francisco biotech developing host-targeted influenza therapies, advancing oral eicosanoid GP1681 and conducting production and toxicology studies toward an IND filing.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors